Core Viewpoint - UnitedHealth Group is facing a class action lawsuit due to potential Medicare fraud investigations by the U.S. Department of Justice, which may impact investor confidence and the company's financial outlook [3][4]. Group 1: Legal Actions and Investigations - A class action has been initiated for investors who purchased UnitedHealth securities between December 3, 2024, and April 16, 2025, with a deadline for filing a lead plaintiff motion set for July 7, 2025 [1]. - The U.S. Department of Justice is conducting a criminal investigation into UnitedHealth Group regarding potential Medicare fraud, focusing on the company's Medicare Advantage business practices [3]. - The investigation has reportedly been ongoing since at least the summer of 2024, although specific details of the alleged misconduct remain unclear [3]. Group 2: Company Developments - On May 13, 2025, UnitedHealth announced the withdrawal of its previously revised financial guidance issued on April 17, indicating potential financial instability [4]. - A leadership change occurred with CEO Andrew Witty stepping down and being succeeded by Chairman and former CEO Stephen Hemsley [4].
UnitedHealth Group Incorporated Investors: Please contact the Portnoy Law Firm to recover your losses. July 7, 2025 Deadline to file Lead Plaintiff Motion